Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production

Clinical trial NCT03852901 · COMPLETED

Trial details

NCT number: NCT03852901
Sponsor: National Institute on Aging (NIA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Empaglifozin Physiological Effects of Drugs Hypoglycemic Agents Sodium-Glucose Transporter 2 Inhibitors

Start date: 2019-03-28
Primary completion: 2020-11-12
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.